hantaan
viru
htnv
caus
hemorrhag
fever
renal
syndrom
hfr
previou
studi
identifi
interferoninduc
transmembran
protein
ifitm
interferonstimul
gene
famili
howev
role
ifitm
htnv
infect
unclear
studi
observ
singl
nucleotid
polymorph
snp
c
allel
cc
genotyp
associ
diseas
sever
htnv
load
plasma
hfr
patient
vitro
experi
show
truncat
protein
produc
c
allel
exhibit
impair
antihtnv
activ
also
prove
abl
inhibit
htnv
infect
huvec
cell
overexpress
rnai
assay
like
via
mechan
inhibit
viru
entri
demonstr
bind
entri
assay
local
late
endosom
also
observ
addit
demonstr
transcript
neg
regul
lncrna
neg
regul
interferon
respons
nrir
taken
togeth
conclud
neg
regul
nrir
inhibit
htnv
infect
snp
correl
plasma
htnv
load
diseas
sever
patient
hfr
associ
sever
diseas
indic
import
viremia
pathogenesi
hfr
therefor
studi
host
factor
limit
htnv
infect
influenc
antivir
respons
well
diseas
progress
clinic
signific
time
human
famili
interferoninduc
transmembran
protein
ifitm
discov
year
ago
consist
interferonstimul
gene
isg
famili
includ
five
member
name
among
possess
antivir
activ
differ
ifitm
protein
differ
antivir
spectrum
exampl
shown
prevent
influenza
viru
infect
vitro
mice
also
inhibit
multipl
virus
includ
filovirus
rhabdovirus
flavivirus
even
ebola
zika
viru
antivir
mechan
thought
restrict
viral
entri
cell
singl
nucleotid
polymorph
snp
singl
nucleotid
variat
genet
sequenc
occur
appreci
frequenc
popul
sever
snp
identifi
among
site
c
allel
result
ntermin
truncat
protein
lead
impair
inhibit
influenza
viru
vitro
notabl
frequenc
c
allel
cc
genotyp
correl
diseas
sever
patient
infect
influenza
viru
htnv
shown
induc
type
interferon
respons
though
later
time
postinfect
overexpress
vero
cell
report
inhibit
htnv
infect
howev
effect
ifitm
htnv
infect
human
cell
line
role
hfr
still
remain
unknown
lncrna
compris
group
noncod
rna
longer
nt
function
gene
regul
lncrna
shown
play
role
innat
immun
among
neg
regul
interferon
respons
nrir
lncrna
nrir
also
known
noncod
isg
neg
regul
express
hcv
infect
notabl
larg
homolog
role
nrir
regul
htnv
infect
remain
unclear
present
studi
investig
effect
replic
htnv
role
develop
hfr
human
provid
primari
evid
suggest
regul
nrir
inhibit
htnv
infect
snp
correl
diseas
sever
viral
load
patient
hfr
studi
expand
understand
antivir
activ
enrich
knowledg
innat
immun
respons
htnv
infect
studi
conduct
accord
recommend
biomed
research
guidelin
involv
human
particip
establish
nation
health
famili
plan
commiss
china
institut
ethic
committe
tangdu
hospit
approv
studi
subject
gave
written
inform
consent
accord
declar
helsinki
inclus
particip
inform
studi
object
sign
consent
form
blood
sampl
medic
record
obtain
sixtynin
hfr
patient
admit
depart
infecti
diseas
tangdu
hospit
octob
march
enrol
studi
patient
han
chines
diagnosi
hfr
made
base
typic
symptom
sign
well
posit
igm
igg
antibodi
htnv
serum
assess
enzym
link
immunosorb
assay
elisa
depart
classif
hfr
sever
exclus
criteria
describ
follow
white
blood
cell
wbc
platelet
plt
blood
urea
nitrogen
bun
serum
creatinin
scr
heteromorph
lymphocyt
test
depart
clinic
laboratori
shown
tabl
accord
clinic
symptom
sign
fever
effus
hemorrhag
edema
renal
function
sever
hfr
classifi
previous
describ
mild
patient
identifi
mild
renal
failur
without
obviou
oligur
stage
moder
patient
obviou
symptom
uremia
effus
bulbar
conjunctiva
hemorrhag
skin
mucou
membran
renal
failur
typic
oligur
stage
sever
patient
sever
uremia
effus
bulbar
conjunctiva
either
peritoneum
pleura
hemorrhag
skin
mucou
membran
renal
failur
oliguria
urin
output
mlday
day
anuria
urin
output
mlday
day
critic
patient
exhibit
follow
sign
ill
refractori
shock
viscer
hemorrhag
heart
failur
pulmonari
edema
brain
edema
sever
secondari
infect
sever
renal
failur
oliguria
urin
output
mlday
day
anuria
urin
output
mlday
day
bun
level
mmoll
due
sampl
quantiti
requir
snp
type
mild
moder
patient
assess
togeth
mild
group
combin
sever
critic
patient
sever
group
exclus
criteria
studi
patient
kidney
diseas
diabet
mellitu
autoimmun
diseas
hematolog
diseas
cardiovascular
diseas
viral
hepat
type
b
c
e
liver
diseas
addit
patient
receiv
corticosteroid
immunomodulatori
drug
studi
period
genom
dna
extract
peripher
blood
patient
use
puregen
dna
isol
kit
gentra
system
minneapoli
mn
usa
region
encompass
human
amplifi
pcr
forward
primer
revers
primer
pcr
product
purifi
sequenc
use
appli
biosystem
dna
analyz
thermo
scientif
waltham
usa
allel
frequenc
genotyp
healthi
han
chines
group
obtain
genom
project
http
htnv
load
plasma
sampl
collect
acut
phase
ageand
sexmatch
hfr
patient
differ
genotyp
measur
use
previous
report
method
briefli
viral
rna
extract
plasma
hfr
patient
use
purelink
viral
rnadna
kit
invitrogen
carlsbad
ca
usa
superscript
iii
platinum
onestep
quantit
rtpcr
system
kit
invitrogen
carlsbad
ca
usa
employ
realtim
rtpcr
assay
primer
probe
provid
sangon
biotech
shanghai
china
follow
forward
revers
probe
fam
atccctcaccttctgcctggctatc
tamra
synthet
segment
htnv
standard
strain
rna
transcript
use
quantit
calibr
extern
standard
cultur
supernat
vero
cell
infect
htnv
quantifi
use
synthet
quantit
calibr
experi
one
aliquot
calibr
standard
extract
parallel
clinic
sampl
serial
dilut
concentr
rang
copiesml
pcr
perform
use
cycler
biorad
hercul
ca
usa
follow
condit
min
min
cycl
fluoresc
read
step
final
segment
everi
cycl
program
huvec
cell
sciencel
research
laboratori
carlsbad
ca
usa
grown
ecm
bulletkit
sciencel
research
laboratori
carlsbad
ca
usa
incub
cell
atcc
cat
rrid
grown
laboratori
dmem
fb
thermo
scientif
waltham
usa
incub
cell
use
within
passag
primari
cultur
htnv
strain
cultur
vero
cell
atcc
cat
rrid
laboratori
titrat
use
immunofluoresc
stain
assay
htnv
nucleocapsid
protein
np
previous
describ
ml
calcul
use
reedmuench
method
recombin
human
obtain
pbl
interferon
sourc
piscataway
nj
usa
dissolv
buffer
provid
manufactur
composit
disclos
huvec
cell
infect
incub
htnv
indic
moi
min
subsequ
viru
solut
remov
fresh
medium
ad
cell
cultur
cell
transfect
lentivir
vector
cmyctag
purchas
genechem
shanghai
china
moi
puromycin
ml
huvec
cell
use
creat
cell
line
stabli
express
ifitm
cell
transfect
control
scrambl
short
interf
rna
sirna
sirna
sirna
sirna
nm
use
lipofectamin
transfect
reagent
invitrogen
carlsbad
ca
usa
sirna
purchas
origen
rockvil
md
usa
sequenc
disclos
total
rna
extract
use
trizol
reagent
invitrogen
carlsbad
ca
usa
cdna
synthes
use
kit
thermo
scientif
waltham
usa
quantit
realtim
pcr
qpcr
perform
use
sybr
premix
ex
taq
ii
takara
biotechnolog
co
dalian
china
biorad
cycler
biorad
hercul
ca
usa
use
refer
gene
primer
sangon
biotech
shanghai
china
follow
forward
revers
forward
revers
forward
revers
premrna
forward
revers
htnv
segment
forward
revers
forward
revers
nrir
forward
revers
nrav
forward
revers
detect
cdna
synthes
use
taqman
microrna
revers
transcript
kit
invitrogen
carlsbad
ca
usa
specif
primer
genespecif
taqman
assay
kit
invitrogen
carlsbad
ca
usa
level
determin
use
genespecif
taqman
assay
kit
invitrogen
carlsbad
ca
usa
invitrogen
carlsbad
ca
usa
use
endogen
control
premrna
level
repres
initi
transcript
rate
primer
use
detect
premrna
design
target
intron
previous
describ
two
exon
one
intron
qpcr
premrna
forward
primer
posit
intron
revers
primer
posit
begin
second
exon
qpcr
mrna
forward
primer
posit
first
exon
revers
primer
posit
begin
second
exon
basal
express
low
cell
detect
mrna
premrna
cell
follow
treatment
iuml
h
overexpress
nrir
cell
lysat
prepar
use
radio
immunoprecipit
assay
ripa
buffer
sigmaaldrich
st
loui
mo
usa
equal
amount
protein
proteinlan
electrophores
sdspolyacrylamid
gel
electrophoret
transfer
polyvinyliden
difluorid
membran
millipor
billerica
usa
block
bovin
serum
albumin
trisbuff
salin
room
temperatur
h
membran
incub
antibodi
proteintech
group
cat
lot
rrid
proteintech
group
cat
lot
rrid
proteintech
wuhan
hubei
china
htnv
np
provid
depart
microbiolog
fourth
militari
medic
univers
overnight
membran
wash
incub
hrpconjug
igg
antibodi
cell
signal
technolog
danver
usa
h
room
temperatur
blot
develop
use
enhanc
chemiluminesc
detect
kit
millipor
billerica
usa
visual
use
xray
film
blot
densiti
analyz
use
quantiti
one
softwar
biorad
hercul
ca
usa
addit
ripa
buffer
contain
tri
ph
mm
nacl
triton
sodium
deoxychol
sd
proteas
inhibitor
cocktail
roch
basel
switzerland
ad
use
cell
cultur
glass
coverslip
millipor
billerica
usa
semiconflu
incub
htnv
min
moi
indic
time
posthtnv
infect
cell
fix
pfa
incub
triton
sigmaaldrich
st
loui
mo
usa
block
bsa
h
follow
incub
mous
monoclon
antibodi
cmyctag
sigmaaldrich
st
loui
mo
usa
sigmaaldrich
cat
lysosomeassoci
membran
glycoprotein
cell
signal
technolog
danver
usa
htnv
np
h
cell
wash
incub
antirabbit
ig
conjug
alexa
antimous
ig
conjug
alexa
abcam
cambridg
usa
secondari
antibodi
room
temperatur
h
nuclei
counterstain
dapi
olympu
fluoresc
microscop
system
confoc
microscopi
system
olympu
tokyo
japan
use
captur
imag
htnv
bind
entri
assay
cell
transduc
empti
vector
detach
wash
extens
cold
pb
cell
htnv
prechil
ice
min
mix
moi
incub
h
rotat
part
cell
wash
extens
icecold
pb
harvest
bind
assay
anoth
part
cell
switch
h
allow
htnv
entri
htnv
remain
cell
surfac
remov
treatment
proteinas
k
mgml
thermo
scientif
waltham
usa
achiev
direct
entri
htnv
cell
virusplasma
membran
fusion
posit
control
cell
prechil
ice
min
mm
adsorpt
htnv
moi
perform
h
cell
wash
fusion
viru
plasma
membran
trigger
incub
low
ph
medium
mm
sodium
succin
ph
min
infect
follow
incub
h
presenc
mm
qpcr
analysi
htnv
segment
conduct
evalu
influenc
ifitm
htnv
cell
adhes
htnv
entri
data
express
mean
sem
statist
analys
perform
use
graphpad
prism
graphpad
softwar
la
jolla
ca
usa
associ
analysi
allel
genotyp
fisher
exact
test
use
independ
sampl
ttest
use
normal
distribut
data
differ
among
group
determin
oneway
analysi
varianc
anova
repeat
measur
follow
bonferroni
post
hoc
test
p
consid
statist
signific
snp
c
allel
cc
genotyp
associ
sever
hfr
diseas
higher
plasma
htnv
load
determin
clinic
signific
snp
htnv
infect
relationship
snp
sever
hfr
patient
examin
sequenc
bp
locu
encompass
snp
enrol
patient
stratifi
patient
mild
sever
base
clinic
assess
describ
section
materi
method
found
significantli
higher
frequenc
c
allel
among
sever
hfr
patient
compar
healthi
han
chines
genom
sequenc
databas
vs
p
frequenc
c
sever
patient
also
higher
mild
patient
vs
p
figur
b
tabl
data
suggest
harbor
c
allel
increas
risk
suffer
sever
diseas
htnvinfect
individu
odd
ratio
ci
genotyp
sever
patient
carri
cc
genotyp
significantli
higher
frequenc
control
han
chines
per
genom
sequenc
databas
cc
genotyp
p
well
mildli
infect
patient
p
figur
b
tabl
howev
mildli
ill
individu
exhibit
fisher
exact
test
use
test
associ
allelegenotyp
hfr
sever
c
plasma
htnv
load
cc
genotyp
patient
cttt
genotyp
patient
test
qrcr
analysi
symbol
repres
one
individu
patient
independ
sampl
ttest
use
test
differ
htnv
load
group
p
p
significantli
differ
genotyp
frequenc
compar
han
chines
popul
addit
also
found
patient
cc
genotyp
higher
plasma
viral
load
acut
phase
figur
result
support
notion
normal
function
play
critic
role
immun
respons
htnv
infect
vivo
substanti
influenc
clinic
manifest
hfr
previou
studi
reveal
truncat
protein
produc
snp
c
allel
figur
miss
part
stand
truncat
amino
acid
ntermin
intramembran
helix
transmembran
helix
present
box
lead
impair
antiinfluenza
activ
test
function
signific
polymorph
htnv
infect
transfect
major
minor
c
variant
allel
produc
fulllength
ntermin
truncat
protein
figur
cmyctag
huvec
cell
use
lentiviru
vector
figur
challeng
cell
htnv
moi
h
found
cell
minor
c
variant
suscept
htnv
infect
higher
express
htnv
segment
figur
posit
htnv
np
figur
supplementari
materi
inde
compar
mock
empti
vector
infect
control
protein
almost
lost
abil
inhibit
htnv
infect
huvec
cell
figur
figur
supplementari
materi
determin
role
htnv
infect
induc
ifitm
qpcr
well
western
blot
ifitm
conduct
huvec
cell
figur
b
figur
supplementari
materi
observ
moder
upregul
mrna
protein
huvec
h
postinfect
mrna
howev
transient
upregul
cell
caus
signific
chang
protein
level
knock
express
transfect
sirna
individu
effect
sirna
express
target
ifitm
test
qpcr
huvec
figur
supplementari
materi
effect
best
oligo
ifitm
test
western
blot
figur
huvec
cell
figur
assess
role
ifitm
antihtnv
effect
knock
respect
transfect
abovetest
oligo
h
follow
treatment
iuml
anoth
h
cell
challeng
htnv
moi
h
htnv
segment
np
level
significantli
suppress
huvec
cell
respons
treatment
notabl
knockdown
significantli
restor
level
htnv
segment
np
huvec
cell
knockdown
also
partial
restor
htnv
level
cell
figur
result
demonstr
assess
antihtnv
effect
ifitm
test
effect
overexpress
htnv
infect
cmyctag
express
huvec
cell
figur
cell
challeng
htnv
moi
h
htnv
segment
np
level
suppress
overexpress
huvec
cell
figur
also
suppress
express
cell
figur
inhibitori
effect
confirm
immunofluoresc
analysi
htnv
np
figur
supplementari
materi
result
accord
abovedescrib
rnai
result
determin
whether
inhibit
htnv
bind
entri
huvec
cell
incub
htnv
moi
h
unbound
viru
wash
away
htnv
rna
collect
time
point
repres
htnv
bound
cell
surfac
viru
bind
cell
shift
h
allow
htnv
intern
htnv
rna
collect
time
point
repres
cellintern
viru
posit
control
inhibit
viru
entri
incub
parallel
group
cell
htnv
ph
describ
section
materi
method
express
affect
htnv
bind
figur
significantli
suppress
htnv
entri
huvec
cell
figur
partial
local
late
endosom
host
cell
elucid
mechan
function
investig
subcellular
local
host
cell
found
partial
local
late
endosom
huvec
analyz
confoc
microscopi
figur
coloc
late
endosom
also
found
cell
transfer
late
endosom
necessari
step
htnv
entri
result
provid
evid
antihtnv
mechan
lncrnaand
micrornamedi
regul
report
sever
studi
test
chang
previous
report
regul
ifitm
nrav
nrir
htnv
infect
among
nrir
chang
one
downregul
htnv
infect
figur
figur
supplementari
materi
huvec
howev
express
nrir
unchang
cell
overexpress
nrir
huvec
cell
use
vector
figur
importantli
overexpress
nrir
significantli
suppress
mrna
premrna
level
facilit
htnv
infect
huvec
cell
figur
data
suggest
lncrna
nrir
neg
regul
transcript
hantaan
viru
envelop
negativesens
rna
viru
genu
hantaviru
within
famili
bunyavirida
caus
hfr
import
threat
public
health
worldwid
also
potenti
weapon
biolog
terror
reservoir
anim
usual
rodent
asymptomat
persist
infect
unlik
rodent
hantaviru
infect
lead
hfr
hantaviru
pulmonari
syndrom
hp
human
major
clinic
characterist
hfr
includ
fever
hemorrhag
hypotens
renal
injuri
caus
sever
manifest
death
case
current
standard
care
hfr
reli
symptomat
support
treatment
confirm
plasma
viral
load
associ
sever
hfr
implic
import
viremia
pathogenesi
hfr
howev
direct
antivir
medic
current
avail
ill
interferon
key
molecul
antivir
respons
use
antivir
medicin
mani
diseas
report
htnv
infect
induc
late
type
interferon
respons
howev
set
isg
requir
ifnmedi
inhibit
htnv
yet
identifi
therefor
identif
isg
effect
htnv
attract
strategi
identifi
novel
therapeut
target
studi
demonstr
significantli
high
frequenc
c
allel
cc
genotyp
among
hfr
patient
sever
ill
compar
mildli
infect
individu
healthi
han
chines
c
allel
cc
genotyp
also
found
associ
higher
plasma
viral
load
earli
stage
hfr
also
discov
htnv
infect
induc
ifitm
truncat
produc
c
allel
exhibit
significantli
decreas
antihtnv
activ
interestingli
found
restrict
htnv
infect
mechan
cellular
entri
inhibit
inde
local
late
endosom
host
cell
necessari
structur
htnv
entri
addit
find
htnv
infect
downregul
lncrna
nrir
h
post
infect
neg
regul
transcript
collect
result
suggest
regul
nrir
inhibit
htnv
infect
snp
correl
diseas
sever
viral
load
patient
hfr
antivir
properti
ifitm
protein
identifi
rnai
screen
host
factor
influenc
influenza
viru
replic
demonstr
possess
antivir
activ
sever
studi
everitt
et
al
demonstr
sever
influenza
viru
infect
greatli
increas
mice
compar
wildtyp
anim
differ
ifitm
member
also
confirm
inhibit
cellular
entri
multipl
viru
famili
includ
filovirus
rhabdovirus
flavivirus
exampl
hcv
infect
inhibit
commonli
believ
ifitm
restrict
viral
infect
stage
cellular
entri
recent
studi
suggest
cellular
locat
differ
ifitm
may
influenc
rang
virus
restrict
protein
prevent
hcv
entri
coloc
cell
membran
interrupt
endocytosi
hcv
particl
wherea
confin
influenza
viru
acidifi
endosom
compart
notabl
retroviru
subviru
particl
isvp
requir
endosom
acidif
entri
inhibit
express
suggest
may
function
stage
endosom
entri
studi
util
cellcel
fusion
assay
suggest
block
entri
envelop
viru
prevent
fusion
viral
membran
limit
membran
host
cell
either
plasma
membran
andor
endosom
membran
result
obtain
use
twophoton
laser
scan
fluoresc
lifetim
imag
flim
suggest
ifitm
protein
may
reduc
membran
fluiditi
increas
spontan
posit
curvatur
outer
leaflet
membran
present
studi
demonstr
u
ml
significantli
inhibit
htnv
infect
sirnamedi
deplet
alon
significantli
mitig
antivir
effect
huvec
cell
wherea
deplet
alon
allevi
antivir
effect
cell
overexpress
inhibit
htnv
infect
huvec
cell
overexpress
also
effect
inhibit
htnv
cell
result
suggest
import
control
factor
natur
infect
htnv
result
also
demonstr
effect
cell
typeindepend
accord
result
similar
virus
rvfv
bind
entri
assay
conduct
control
temperatur
ph
show
significantli
influenc
htnv
bind
inhibit
htnv
entri
huvec
cell
inde
partial
local
late
endosom
host
cell
necessari
site
htnv
entri
howev
fail
track
transport
htnv
infect
cell
possibl
due
lack
fluorescencelabel
viru
addit
also
suppress
htnv
infect
cell
mechan
underli
antihtnv
effect
remain
undetermin
deserv
explor
accord
recent
studi
threedimension
structur
ctermin
transmembran
twontermin
intramembran
shown
figur
black
box
two
splice
variant
differ
presenc
absenc
first
ntermin
amino
acid
delet
part
shown
figur
red
dot
line
sever
snp
includ
nonsynonym
synonym
infram
stop
splice
site
acceptoralt
report
translat
sequenc
among
rare
snp
allel
truncat
protein
describ
lead
reduc
inhibit
influenza
viru
infect
cell
demonstr
truncat
protein
also
lose
abil
inhibit
htnv
infect
vitro
northern
european
patient
hospit
season
influenza
pandem
influenza
viru
increas
homozygos
minor
c
allel
snp
observ
chines
patient
infect
influenza
viru
also
increas
frequenc
c
allel
cc
genotyp
snp
present
studi
observ
increas
frequenc
c
allel
cc
genotyp
snp
sever
infect
hfr
patient
compar
healthi
control
mildli
affect
patient
patient
carri
cc
genotyp
also
higher
plasma
viral
load
compar
cttt
genotyp
given
impair
function
protein
produc
c
mutat
fact
enrich
c
allel
patient
sever
diseas
higher
viral
load
patient
cc
genotyp
found
suggest
play
pivot
role
antihtnv
respons
vivo
specul
much
higher
level
cc
allel
healthi
popul
han
chines
compar
caucasian
may
place
chines
higher
risk
develop
sever
ill
upon
htnv
infect
need
investig
lncrna
group
noncod
rna
longer
nt
function
gene
regul
play
role
regul
multipl
cellular
function
includ
innat
immun
exampl
lncrna
report
upregul
influenza
viru
polyi
c
stimul
promot
express
lncrna
nrav
shown
neg
regul
initi
transcript
affect
histon
modif
gene
lncrna
nrir
noncod
isg
report
neg
regul
express
hcv
infect
also
report
regul
analysi
lncrna
nrir
downregul
huvec
htnv
infect
h
overexpress
nrir
neg
regul
initi
transcript
evidenc
decreas
premrna
well
mrna
level
nrir
overexpress
also
facilit
htnv
infect
result
indic
downregul
nrir
htnv
infect
possibl
involv
activ
innat
immun
respons
htnv
infect
also
evalu
potenti
regul
choos
nrir
studi
anoth
lncrna
regul
ie
nrav
remain
unchang
htnv
infect
figur
b
supplementari
materi
addit
potenti
regul
also
unalt
htnv
infect
figur
supplementari
materi
conclus
studi
reveal
critic
role
htnv
infect
demonstr
first
time
knowledg
newli
identifi
antihtnv
isg
express
neg
regul
nrir
antivir
activ
seem
via
mechan
inhibit
viru
entri
host
cell
addit
discov
snp
c
allel
cc
genotyp
correl
plasma
htnv
load
sever
hfr
c
allel
produc
truncat
protein
attenu
antihtnv
function
result
provid
new
insight
role
regul
innat
immun
htnv
infect
basi
identifi
new
target
develop
novel
agent
worldwid
infecti
diseas
author
contribut
zxi
bpi
yct
mhw
perform
experi
wpz
bxf
lyf
zy
jz
design
research
hcx
yw
wx
analyz
data
tk
zcm
provid
clinic
data
zxi
bpi
wrote
paper
